1. Home
  2. GMAB vs HTHT Comparison

GMAB vs HTHT Comparison

Compare GMAB & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMAB
  • HTHT
  • Stock Information
  • Founded
  • GMAB 1999
  • HTHT 2005
  • Country
  • GMAB Denmark
  • HTHT China
  • Employees
  • GMAB N/A
  • HTHT N/A
  • Industry
  • GMAB Biotechnology: Pharmaceutical Preparations
  • HTHT Hotels/Resorts
  • Sector
  • GMAB Health Care
  • HTHT Consumer Discretionary
  • Exchange
  • GMAB Nasdaq
  • HTHT Nasdaq
  • Market Cap
  • GMAB 12.1B
  • HTHT 10.2B
  • IPO Year
  • GMAB N/A
  • HTHT 2010
  • Fundamental
  • Price
  • GMAB $24.14
  • HTHT $37.51
  • Analyst Decision
  • GMAB Buy
  • HTHT Strong Buy
  • Analyst Count
  • GMAB 9
  • HTHT 4
  • Target Price
  • GMAB $40.71
  • HTHT $46.75
  • AVG Volume (30 Days)
  • GMAB 1.2M
  • HTHT 2.0M
  • Earning Date
  • GMAB 05-01-2025
  • HTHT 03-19-2025
  • Dividend Yield
  • GMAB N/A
  • HTHT 1.68%
  • EPS Growth
  • GMAB 83.82
  • HTHT 16.88
  • EPS
  • GMAB 16.85
  • HTHT 1.66
  • Revenue
  • GMAB $2,988,286,182.00
  • HTHT $3,343,360,178.00
  • Revenue This Year
  • GMAB $19.59
  • HTHT $9.89
  • Revenue Next Year
  • GMAB $14.50
  • HTHT $6.88
  • P/E Ratio
  • GMAB $14.08
  • HTHT $22.56
  • Revenue Growth
  • GMAB 30.67
  • HTHT 17.24
  • 52 Week Low
  • GMAB $18.64
  • HTHT $27.03
  • 52 Week High
  • GMAB $31.88
  • HTHT $42.98
  • Technical
  • Relative Strength Index (RSI)
  • GMAB 71.05
  • HTHT 62.78
  • Support Level
  • GMAB $23.63
  • HTHT $35.45
  • Resistance Level
  • GMAB $24.11
  • HTHT $37.83
  • Average True Range (ATR)
  • GMAB 0.37
  • HTHT 1.16
  • MACD
  • GMAB 0.22
  • HTHT 0.07
  • Stochastic Oscillator
  • GMAB 93.88
  • HTHT 62.73

About GMAB Genmab A/S ADS

Genmab AS is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

About HTHT H World Group Limited

H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, manachised, and franchised models. The company has two operating segments; legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.

Share on Social Networks: